welcoming members from all backgrounds



15-19 May 2022

Athens, OH

Registration Deadline:
11 May 2022
Registration Fee:

See website


This meeting is generously supported by the Journal of Neuroendocrinology Symposium Support Grant.

The aim of this FASEB Science Research Conference (SRC) is to improve our understanding of the regulation and action of growth hormone (GH) and prolactin (PRL) and their specific receptors.

It is well established that GH and PRL regulate growth and lactation, respectively. It is now clear, however, that "GH/PRL hormones" define a family of hormones acting through cytokine receptors, with actions that extend far beyond their originally identified physiological functions—these include regulation of metabolism, inflammation, angiogenesis, fetal programming, cell (stem) recruitment/ proliferation, behavior, and neurogenesis—with implications for the etiology and treatment of diseases such as type-2 diabetes, obesity, arthritis, osteoporosis, psychiatric disorders and cancer.

This SRC evolved from a long-standing prolactin conference that expanded in scope to cover the wide range of functions of the growth hormone/prolactin family of hormones. It has been running under the FASEB banner since 2012 with a worthy goal: that the mixture of fundamental basic science through to clinical research into these pleiotropic hormones will accelerate the translation of knowledge into novel clinical applications.

The conference will present and integrate novel research advances in GH/PRL biology to raise the profile of the field and foster new national and international collaborative projects. A key aspect is to encourage and support emerging investigators/trainees and the participation of under-represented groups.